Type 2 Diabetes Mellitus and Hypertension

Cited by (307)

Items 101–200 of 307

1. Prevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study
   Junwei Wang, Aiping Wang, Mingyun Chen, Junxi Lu, Jiang-Feng Ke, Lianxi Li, Weiping Jia · 2019 · Diabetology & Metabolic Syndrome
2. Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
   for the ATTEND investigators, Changyuan Liu, Wei Zhang, Linong Ji, Ji‐Guang Wang · 2019 · Diabetology & Metabolic Syndrome
3. Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type II Diabetes: Current Clinical Evidence and Future Perspectives
   Roodabeh Bahramsoltani, Mohammad Hosein Farzaei, Mahboobe Ram, Shekoufeh Nikfar, Roja Rahimi · 2021 · Evidence-based Complementary and Alternative Medicine
4. Mining the sociome for Health Informatics: Analysis of therapeutic lifestyle adherence of diabetic patients in Twitter
   Gael Pérez Rodríguez, Martín Pérez‐Pérez, Florentino Fdez‐Riverola, Anália Maria Garcia Lourenço · 2020 · Future Generation Computer Systems
5. The association between hypertension and other cardiovascular risk factors among non-diabetic Saudis adults–A cross sectional study
   Ghada Ajabnoor, Suhad Bahijri, Aliaa A. Alamoudi, Rajaa Mohammad Al-Raddadi, Jawaher Al-Ahmadi, Hanan Jambi, Anwar Borai, Jaakko Toumilehto · 2021 · PLoS ONE
6. Diabetes, Hypertension, and the Mediating Role of Lifestyle: A Cross-Sectional Analysis in a Large Cohort of Adults
   Pedro L. Valenzuela, Alejandro Santos‐Lozano, Adrián Castillo‐García, Luis Miguel Ruilope, Alejandro Lucía · 2022 · American Journal of Preventive Medicine
7. The Causal Effect of Systolic Blood Pressure Lowering on Vascular Outcomes in Diabetes: A Mendelian Randomization Study
   Tianzhichao Hou, Mian Li, Hong Lin, Zhiyun Zhao, Jieli Lu, Tiange Wang, Yu Xu, Weiqing Wang, Yufang Bi, Guang Ning et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
8. Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus
   Joris Holtrop, Wilko Spiering, Hendrik M. Nathoe, Gert Jan de Borst, Laurens Jaap Kappelle, Harold W. de Valk, Frank L.J. Visseren, Jan Westerink · 2019 · Journal of Hypertension
9. A Machine Learning Model to Predict Length of Stay and Mortality among Diabetes and Hypertension Inpatients
   Diana Barsasella, Karamo Bah, Pratik Mishra, Mohy Uddin, Eshita Dhar, Dewi Lena Suryani, Dedi Rahmat Setiadi, Imas Masturoh, Ida Sugiarti, Jitendra Jonnagaddala et al. · 2022 · Medicina
10. Development and Comparison of Three Data Models for Predicting Diabetes Mellitus Using Risk Factors in a Nigerian Population
    Oluwakemi Ololade Odukoya, Solomon Chiekezi Nwaneri, Ifedayo Adeola Odeniyi, Babatunde Abdulmajeed Akodu, Esther Oluwakemi Oluwole, Gbenga Olorunfemi, Oluwatoyin P. Popoola, Akinniyi Adediran Osuntoki · 2022 · Healthcare Informatics Research
11. Single Nucleotide Polymorphism in the ADIPOQ Gene Modifies Adiponectin Levels and Glycemic Control in Type Two Diabetes Mellitus Patients
    Mahmoud A. Alfaqih, Aisha Al-hawamdeh, Zouhair Odeh Amarin, Yousef Saleh Khader, Khawla Mhedat, Mohammed Zohair Allouh · 2022 · BioMed Research International
12. Poor quality of sleep in Mexican patients with type 2 diabetes and its association with lack of glycemic control
    Irene Suárez-Torres, Fabio García‐García, Jaime Morales‐Romero, Montserrat Alheli Melgarejo-Gutiérrez, Verónica Patricia Demeneghi-Marini, Rosa Isela Luna-Ceballos, Cirenia Hernández Trejo, Diana Aurora Carmona Cortés · 2023 · Primary care diabetes
13. Serum Branched Chain Amino Acids Are Associated with Type 2 Diabetes Mellitus in Jordan
    Mahmoud A. Alfaqih, Zaina E. Abu-Khdair, Rami Saadeh, Nesreen A. Saadeh, Ahmed Al‐Dwairi, Othman Abdullah Al-Shboul · 2018 · Korean Journal of Family Medicine
14. Diabetes mellitus in ankylosing spondylitis
    Young Ho Lee, Gwan Gyu Song · 2019 · Annals of the Rheumatic Diseases
15. Prevalence of, and risk factors for, diabetes and prediabetes in Bangladesh: Evidence from the national survey using a multilevel Poisson regression model with a robust variance
    Mohammad Bellal Hossain, Md Nuruzzaman Khan, John C. Oldroyd, Juwel Rana, Dianna J. Magliano, E. Chowdhury, Md Nazmul Karim, Rakibul M. Islam · 2021 · medRxiv
16. Prevalence of hypertension among individuals with diabetes and its determinants: evidences from the National Family Health Survey 2015–16, India
    Arpita Santra, Akash Mallick · 2022 · Annals of Human Biology
17. Suboptimal blood pressure control and its associated factors among people living with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis
    Yonas Akalu, Yigizie Yeshaw, Getayeneh Antehunegn Tesema, Sofonyas Abebaw Tiruneh, Achamyeleh Birhanu Teshale, Dessie Abebaw Angaw, Misganaw Gebrie Worku, Baye Dagnew · 2022 · Systematic Reviews
18. Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
    Pinaki Sengupta, Bappaditya Chatterjee, Tapan Kumar Pal · 2017 · Regulatory Toxicology and Pharmacology
19. Static Magnetic Field Versus Systemic Calcium Channel Blockade Effect on Microcirculation: Possible Mechanisms and Clinical Implementation
    Juraj Gmitrov · 2020 · Bioelectromagnetics
20. Metformin Alleviates Diabetes-Associated Hypertension by Attenuating the Renal Epithelial Sodium Channel
    Yogesh M. Scindia, Mohammed F. Gholam, Alina Waleed, Lauren Liu, Kevin M. Chacko, Dhruv N. Desai, Juliana Pena Lopez, Zeeshan S. Malik, Whitney C. Schramm, Angelica G. Morales et al. · 2023 · Biomedicines
21. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus
    Yuerong Yan, Fengqiu Hu, Weilu Wu, Ruiting Ma, Hui Huang · 2017 · Medicine
22. Multicomponent Exercise Improves Hemodynamic Parameters and Mobility, but Not Maximal Walking Speed, Transfer Capacity, and Executive Function of Older Type II Diabetic Patients
    Hélio José Coelho‐Júnior, Íris Callado Sanches, Márcio Doro, Ricardo Yukio Asano, Daniele Jardim Feriani, Cayque Brietzke, Ivan de Oliveira Gonçalves, Marco Carlos Uchida, Érico Chagas Caperuto, Bruno Rodrigues · 2018 · BioMed Research International
23. New-onset diabetes in hypertensive patients and mortality: timing is everything
    Rosa María Bruno, Stefano Taddei · 2015 · European Heart Journal
24. Association of SLC30A8 rs13266634 gene polymorphism with type 2 diabetes mellitus (T2DM) in a population of Noakhali, Bangladesh: a case–control study
    Farhana Siddiqi Mitu, Md. Murad Hossain, Shuvo Chandra Das, Mohammed Mafizul Islam, Dhirendra Nath Barman, Shipan Das Gupta · 2024 · Egyptian Journal of Medical Human Genetics
25. Endothelial pulsatile shear stress is a backstop for COVID-19
    Marvin A. Sackner, José A. Adams · 2020 · Emerging Topics in Life Sciences
26. Clinical effect of nonsteroidal mineralocorticoid receptor (MR) antagonists in the treatment of diabetic kidney disease: expectations as a new therapeutic strategy
    Atsuhisa Sato, Mitsuhiro Nishimoto · 2022 · Hypertension Research
27. Diabetic microvascular complications among adults with type 2 diabetes in Adama, central Ethiopia
    Yohannes Mekuria Negussie, Midekso Sento, Nesra Mohammed Fati · 2024 · Scientific Reports
28. Resistant Hypertension in Diabetes Mellitus
    Pedro Armario · 2015 · Journal of Endocrinology and Diabetes
29. Short‐term effects of perindopril‐amlodipine vs perindopril‐indapamide on blood pressure control in sub‐Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double‐blinded randomized controlled trial
    Eugène Sobngwi, Liliane Mfeukeu‐Kuate, Merveille Florence Kouam Simo, Aurel Tiakouang Tankeu, Chris Nadège Nganou–Gnindjio, Bâ Hamadou, Martine Claude Etoa Etoga, E. Ngassam, Ariane Nkamgna, Mesmin Yefou Dehayem et al. · 2019 · Journal of Clinical Hypertension
30. Suboptimal Blood Pressure Control, Associated Factors, and Choice of Antihypertensive Drugs among Type 2 Diabetic Patients at KCMC, Tanzania
    Gabriel W. Mbwete, Kajiru Kilonzo, Elichilia Robert Shao, Nyasatu Godfrey Chamba · 2020 · Journal of Diabetes Research
31. Effect of a nurse-led lifestyle choice and coaching intervention on systolic blood pressure among type 2 diabetic patients with a high atherosclerotic cardiovascular risk: study protocol for a cluster-randomized trial
    William Lumu, Davis Kibirige, Ronald Wesonga, Silver Bahendeka · 2021 · Trials
32. Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus
    Bikash Ranjan Meher, Rashmi Ranjan Mohanty, Jyoti Prakash Sahoo, Monalisa Jena, Anand Srinivasan, Biswa Mohan Padhy · 2022 · Cureus
33. Not Only COVID-19: Involvement of Multiple Chemosensory Systems in Human Diseases
    Antonio Caretta, Carla Mucignat‐Caretta · 2022 · Frontiers in Neural Circuits
34. Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: The German T2Target registry
    Thomas Mengden, Uwe Ligges, Johanna Mielke, Peter Bramlage, Andrea Korzinek, Walter Sehnert · 2017 · Journal of Clinical Hypertension
35. Impact of lifestyle education for type 2 diabetes mellitus
    Jingjing Zhu, Min Chen, Yuzi Pang, Shumin Li · 2021 · Medicine
36. Neck and Wrist Circumferences as Indicators of Metabolic Alterations in the Pediatric Population: A Scoping Review
    Evelyn Valencia-Sosa, Guillermo Julián González Pérez, Erika Martínez‐López, Roberto Rodriguez‐Echevarría · 2021 · Children
37. Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of “real world” data
    Quintí Foguet Boreu, Concepción Violán, Tomás López‐Jiménez, Mariona Pons‐Vigués, Teresa Rodríguez-Blanco, José M Valderas, Marina Guisado‐Clavero, Enriqueta Pujol Ribera · 2017 · Primary care diabetes
38. MicroRNA-216b actively modulates diabetic angiopathy through inverse regulation on FZD5
    Yuxiang Dai, Hao Lu, Shen Wang, Shufu Chang, Chenguang Li, Zheyong Huang, Feng Zhang, Hongbo Yang, Yi Shen, Zhangwei Chen et al. · 2018 · Gene
39. Association Between Abdominal Obesity, Body Mass Index, and Hypertension in India: Evidence From a Large Nationally Representative Data
    Rajat Das Gupta, Mohammad Rifat Haider, Simanta Roy, Mohammad Rashidul Hashan, Amrit Baral, Nowrin Tamanna, Ananna Mazumder, Shams Shabab Haider, Biplab Kumar Datta · 2025 · Journal of Clinical Hypertension
40. Effect of Patient Support Groups for Hypertension on Blood Pressure among Patients with and Without Multimorbidity: Findings from a Cohort Study of Patients on a Home-Based Self-Management Program in Kenya
    Peter Otieno, Charles O Agyemang, Calistus Wilunda, Richard E. Sanya, Samuel Iddi, Welcome Mkululi Wami, Judith M. van Andel, Babette van der Kloet, Julia Teerling, Angela Siteyi et al. · 2023 · Global Heart
41. Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study
    Kimiko Sakai, Takuro Okamura, Ema Toyokuni, Hiroshi Okada, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui · 2024 · Journal of Diabetes Investigation
42. Trends in predicted 10-year risk for cardiovascular diseases among patients with type 2 diabetes in Thailand, from 2014 to 2018
    Sethapong Lertsakulbunlue, Mathirut Mungthin, Ram Rangsin, Anupong Kantiwong, Boonsub Sakboonyarat · 2023 · BMC Cardiovascular Disorders
43. Factors of Health Promotion Behaviour (HPB) and Elderly Health Diseases in Malaysia
    Mohammed Awal Iddrisu, Abdelhak Senadjki, Charles Ramendran SPR, Hui Nee Au Yong, King Tak Yew, Veronica Poulsaeman · 2020 · Journal of Population Ageing
44. Genes, Genetic Polymorphism, Diet, Soluble Mediators, and Their Role in the Pathobiology of Type 2 Diabetes Mellitus and Hypertension
    Undurti Narasimha Das · 2021 · American Journal of Hypertension
45. Effectiveness of a nurse-led management intervention on systolic blood pressure among type 2 diabetes patients in Uganda: a cluster randomized trial
    William Lumu, Silver Bahendeka, Davis Kibirige, Ronald Wesonga, Ronald Kasoma Mutebi · 2024 · Clinical Diabetes and Endocrinology
46. Factores asociados a complicaciones crónicas de diabetes mellitus tipo 2 en pacientes de un hospital general del Seguro Social de Salud del Perú
    Juan Villacorta Santamato, Nélida Hilario Huapaya, Jorge Inolopú-Cucche, Leonel Terrel-Gutierrez, Rosa Labán Hijar, José Del Aguila, César Ugarte‐Gil, Yamilée Hurtado-Roca · 2020 · Anales de la Facultad de Medicina
47. A measurement error Rao–Yu model for regional prevalence estimation over time using uncertain data obtained from dependent survey estimates
    Jan Pablo Burgard, Joscha Krause, Domingo Morales · 2021 · Test
48. Tobacco smoking and blood pressure: How are they related among the Indians? – A secondary analysis of National Family Health Survey (NFHS)-4 data
    Barsha Gadapani Pathak, S Rahini, Rukman Mecca Manapurath, Sharath Burugina Nagaraja, Rakesh Gupta, Sonu Goel · 2022 · Journal of Family Medicine and Primary Care
49. Insulin receptor substrate-1 gene polymorphism and lipid panel data in type 2 diabetic patients with comorbid obesity and/or essential hypertension
    М. І. Марущак, L Mazur, Іnna Krynytska · 2023 · Endocrine Regulations
50. The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney
    Jennifer Rose Matthews, Moira E. Hibbs, Lakshini Yasaswi Herat, Markus Peter Schlaich, Vance Bruce Matthews · 2023 · Biomedicines
51. Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial
    Ruixue Yang, Yanqi Zhu, Mengdan Xu, Yanhua Tao, Wenwen Cong, Jun Cai · 2023 · European Journal of Preventive Cardiology
52. Attributable risk of all-cause mortality in hypertensive adults based on disease risk prediction model: A Chinese cohort study
    Weiwei Sun, Yanhong Huo, Qingqing Liu, Andrew C. Ahn, Jingwei Zhou, Ruichao Yu, Zhenjie Chen, Yaoxian Wang, Hongfang Liu · 2020 · Journal of Infection and Public Health
53. Cardiovascular Complications in Patients with Turner’s Syndrome
    Eirini Kostopoulou, Julia Κ. Bosdou, Panagiotis G. Anagnostis, John C. Stevenson, Dimitrios G. Goulis · 2020 · Current Pharmaceutical Design
54. Penilaian Risiko Interaksi Obat pada Pasien dengan Diabetes Melitus Tipe 2
    Indriastuti Cahyaningsih, Winda Ayu Wicaksono · 2020 · Indonesian Journal of Clinical Pharmacy
55. Prostaglandylinositol cyclic phosphate, the natural antagonist of cyclic AMP
    H.K. Wasner · 2020 · IUBMB Life
56. Preclinical Trial of Propolis Extract in Prevention of High Salt Diet- Induced Hypertension
    Ade Heri Mulyati, Ahmad Sulaeman, Sri Anna Marliyati, Mohamad Rafi, Al Mukhlas Fikri · 2021 · Pharmacognosy Journal
57. Arterial Hypertension
    Francesco Paneni, Francesco Cosentino · 2015 · Springer eBooks
58. Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”
    Keisuke Okamura, Yuiko Yano, Yosuke Takamiya, Kazuyuki Shirai, Hidenori Urata · 2019 · Clinical and Experimental Hypertension
59. Lifestyle behaviors and serum vitamin C in the Thai population in Bangkok Metropolitan
    Somchai Boonpangrak A, Tanawut Tantimongcolwat, Lertyot Treeratanapiboon, Pairoj Leelahakul, Virapong Prachayasittikul · 2018 · EXCLI journal
60. Treatment of hypertension in diabetes: a contemporary approach with a focus on improving cardiovascular outcomes
    Darshan Khangura, L. Romayne Kurukulasuriya, James R. Sowers · 2015 · Expert Review of Endocrinology & Metabolism
61. Combining Theory-Driven Realist Approach and Systems Thinking to Unpack Complexity of Type 2 Diabetes and Hypertension Management in Low and Middle-Income Countries: Protocol for a Realist Review
    Fatemeh Ehteshami, Rachel Cassidy, Fabrizio Tediosi, Günther Fink, Daniel Cobos Muñoz · 2024 · Systems
62. Hypertension attenuates the link of osteoprotegerin to reduced baroreflex sensitivity in type 2 diabetes mellitus patients on oral antidiabetic and antihypertensive therapy – a cross sectional study
    A. Naga Sailaja, Nivedita Nanda, Bettadpura Shamanna Suryanarayana, G K Pal · 2022 · BMC Endocrine Disorders
63. Engineering nanosystems for transdermal delivery of antihypertensive drugs
    Mingliang Fan, Wengang Liu, Liangfeng Zhao, Lirong Nie, Yu Wang · 2024 · Pharmaceutical Development and Technology
64. An elastic net penalized small area model combining unit- and area-level data for regional hypertension prevalence estimation
    Jan Pablo Burgard, Joscha Krause, Ralf Thomas Münnich · 2020 · Journal of Applied Statistics
65. The association between nicotinamide N-methyltransferase gene polymorphisms and primary hypertension in Chinese Han Population
    Xiang-Xiang Guan, Xiaojuan Zhu, Zhaohui Deng, Yu-Rong Zeng, Jie-Ru Liu, Jiang-Hua Li · 2021 · AIMS bioengineering
66. Hypertensive Phenotypes and Pattern of Ambulatory Blood Pressure in Patients of Diabetes Mellitus of Kashmir Valley
    Tariq A. Bhat, Mohammad R. Mir, Shaariq Mehraj Naqati, Muzafar Ahmed Naik, Mubarik Naqash · 2022 · Indian Journal of Endocrinology and Metabolism
67. Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats
    Emuesiri Goodies Moke, Eric K. I. Omogbai, Sammydavies E. Osagie-Eweka, Adaeze Phina Uchendu, MARTHA O OBAYUWANA, Elizabeth Okoro-Akpandu, Benneth Ben‐Azu · 2023 · Laboratory Animal Research
68. Meal patterns and incident hypertension in community-dwelling middle-aged adults: an 11-year follow-up cohort study
    Xianwen Shang, Alison Flehr, Yujie Fang, Mingguang He · 2021 · Journal of Hypertension
69. Role of chlorhexidine on tracheostomy cannula decontamination in relation to the growth of Biofilm-Forming Bacteria Colony- a randomized controlled trial study
    Syahrial Marsinta Hutauruk, Bambang Hermani, Putri Monasari · 2021 · Annals of Medicine and Surgery
70. Coexistence of Diabetes Mellitus and Hypertension
    Adel E. Berbari, Najla A. Daouk, Edgar M. Nasr · 2023 · Updates in hypertension and cardiovascular protection
71. Mediating effect of BMI on the association of economic status and coexistence of hypertension and diabetes in Bangladesh: A counterfactual framework‐based weighting approach
    Foyez Ahmmed, Md. Jamal Hossain, Md Tareq Ferdous Khan, Muhammad Mahabub Rahaman Manik, Saimon Shahriar, Dulal Chandra Nandi, Md Parvej Hussain · 2024 · Health Science Reports
72. Management of Diabetes Mellitus
    Alicia Josephine Jenkins, EMMA S. SCOTT, Jordan Fulcher, Gary Kilov, Andrzej S. Januszewski · 2018 · Contemporary cardiology
73. Modern Phytomedicine in Treating Diabetic Foot Ulcer: Progress and Opportunities
    Mohamed Ali‐Seyed, Siddiqua Ayesha · 2020 · Springer eBooks
74. Searching For Prediabetes before Diabetes
    Gian Piero Carnevale Schianca, Mattia Bellan · 2016 · General Medicine Open Access
75. The Influence of Mat Pilates Training on Cardiometabolic Risk Factors in Postmenopausal Women with Single or Multiple Cardiometabolic Diseases
    Jaqueline Pontes Batista, Ana Luiza Amaral, Igor Moraes Mariano, Ludimila Ferreira Gonçalves, Júlia Buiatte Tavares, Tállita Cristina Ferreira de Souza, Juliene Gonçalves Costa, Mateus de Lima Rodrigues, Jair Pereira Cunha-Junior, Karine Canuto Loureiro de Araújo et al. · 2025 · International Journal of Environmental Research and Public Health
76. Determination diabetes mellitus disease markers in tear fluid by photothermal AFM-IR analysis
    Dária Kondrakhova, Miriam V. Unger, Hartmut Stadler, Katarína Zakuťanská, Natália Tomašovičová, Vladimı́ra Tomečková, Jakub Horák, Taťiana Kimáková, Vladimír Komanický · 2025 · Nanomedicine Nanotechnology Biology and Medicine
77. The scope of a comprehensive primary healthcare approach in addressing the rising burden of noncommunicable diseases
    Senthilkumar Ramasamy, Suganya Panneerselvam, Pitchaimani Govindharaj, Sanjana Agarwal · 2025 · International Journal of Noncommunicable Diseases
78. Pharmacist interventions to improve hypertension management among patients with diabetes: a systematic review and meta-analysis of randomized controlled trials
    Viktoria Gastens, Stefano Tancredi, Dylan Bonnan, Blanche Kiszio, Cinzia Del Giovane, Ross T. Tsuyuki, Gilles Paradis, Arnaud Chioléro, Line Guénette, Valérie Santschi · 2025 · BMC Health Services Research
79. Disability assessment of individuals with diabetes mellitus: a cross-sectional study with the WHODAS 2.0
    Andressa Camargo, Debora Boguchewski Campos, Aline Aparecida Chociai de Lima, Gladson Ricardo Flôr Bertolini, Andersom Ricardo Fréz, Aline Cristiane Binda · 2022 · Fisioterapia e Pesquisa
80. Risk Estimate of Complications in Type 2 Diabetes Using Ensemble Learning and Deep Learning
    Kanika Sood, Aneesh Reddy Sannapu · 2023 · IEEE World AI IoT Congress (AIIoT)
81. The Burden of Undiagnosed Hypertension and Associated Risk Factors among Adults in a Rural Community in Imo Sate, South-East Nigeria
    Iwunze Anuli, Jideuma Ikenna Egwim, Onuoha Frank, Olekanma Chinonye, Ndukwu Chiagozie, Hope Igbonagwam, Dike Victor · 2024 · International Journal of Clinical Medicine
82. Sympathetic Activation Promotes Sodium Glucose Co-Transporter-1 Protein Expression in Rodent Skeletal Muscle
    Jennifer R. Matthews, Lakshini Yasaswi Herat, Markus Peter Schlaich, Vance Bruce Matthews · 2024 · Biomedicines
83. Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes
    Margarita Saiz-Satjes, Francisco Javier Martínez-Martín · 2018 · Drugs in Context
84. Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
    Fabiola Carrara, Piero Luigi Ruggenenti, Annalisa Perna, Ilian Petrov Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Carlo Bossi, Roberto Trevisan, Giuseppe Remuzzi et al. · 2021 · Acta Diabetologica
85. The bee propolis for preventing and healing non-communicable diseases
    Ahmad Sulaeman, Al Mukhlas Fikri, Ade Heri Mulyati · 2021 · Elsevier eBooks
86. Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes
    Masato Kase, Toshie Iijima, Takafumi Niitani, Masaaki Sagara, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso · 2022 · Diabetology International
87. Serum bicarbonate concentration and the risk of death in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Stephen A. Paul Chubb, Wendy Angela Davis, Timothy M. E. Davis · 2023 · Acta Diabetologica
88. Prevalence of obesity, diabetes and hypertension in immigrant populations in northeastern Mexico
    Guillermo Baudelio Gómez-Morales, Brenda Sofía Rosas-Torres, Williams Jesús Hernández-Jiménez, Estefanía Mattenberger-Cantú, Javier Vargas‐Villarreal, Horacio Eusebio Almanza-Reyes, Francisco González‐Salazar · 2024 · Frontiers in Public Health
89. Diabetes and Hypertension
    Samy I. McFarlane, Amal F. Farag, David Gardner, James R. Sowers · 2005 · Humana Press eBooks
90. Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study
    Moluk Hadi Alijanvand, Ashraf Aminorroaya, Iraj Kazemi, Sima Aminorroaya Yamini, Mohsen Janghorbani, Masoud Amini, Marjan Mansourian · 2019 · Diabetes Metabolic Syndrome and Obesity
91. The Impact of HPB on Elderly Diseases (Diabetes Mellitus, Hypertension, Hypercholesterolemia, Minor Stroke, Kidney Failure and Heart Problem): a Logistic Analysis
    Mohammed Awal Iddrisu, Abdelhak Senadjki, Saidatulakmal Binti Mohd, Charles Ramendran, Chee Yin Yip, Lin‐Sea Lau · 2020 · Ageing International
92. Diabetes and Hypertension
    Dharshan Khangura, Jang Hee Hong, R. Kurukulasuriya, James R. Sowers · 2019 · Springer eBooks
93. First‐dose effect of the SGLT 2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats
    Shoji Takakura, Toshiyuki Takasu · 2018 · Clinical and Experimental Pharmacology and Physiology
94. Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidity
    Vincent Pascat, Liudmila Zudina, Lucas Maurin, Anna Ulrich, Jared G. Maina, Ayşe Demirkan, Zhanna Balkhiyarova, Igor Pupko, Yevheniya Sharhorodska, François N. Pattou et al. · 2026 · Nature Communications
95. Screening for identifying individuals at risk of developing type 2 diabetes using the Canadian diabetes risk (CANRISK) questionnaire
    Elida Zairina, Arie Sulistyarini, Gesnita Nugraheni, Sindy Irvana Kurnia Saputri, Ayudika Permatasari, Elinda Eka Rachmawati · 2021 · Journal of Public Health
96. Detrimental Effect of C-Reactive Protein on the Cardiometabolic Cells and Its Rectifying by Metabolic Surgery in Obese Diabetic Patients
    Fang Sun, Zhigang Zhao, Qiang Li, Xunmei Zhou, Yingsha Li, Hexuan Zhang, Zhencheng Yan, Hongbo He, Zhigang Ke, Yu Gao et al. · 2020 · Diabetes Metabolic Syndrome and Obesity
97. Fuzzy Near Compactness Based Personalized Recommendation for Preventing Patients with Type 2 Diabetes Mellitus and Hypertension from Cardiovascular Complication
    Napa Rachata, Worasak Rueangsirarak, Chayapol Kamyod, Punnarumol Temdee · 2020 · Wireless Personal Communications
98. Tip 2 Diyabetli Bireylerin Beslenme Durumlarının Saptanması ve Diyabete Yönelik Davranışlarının Belirlenmesi
    Gülşah Kaner, Barış Önder Pamuk, Gülseren Pamuk, Dilek Ongan, Ezgi Bellikci Koyu, Gamze Çalık, Serap ÖKSÜZ · 2021 · Turkish Journal of Diabetes and Obesity
99. Magnitud y Factores asociados a complicaciones de diabetes tipo 2: Análisis de un Sistema de Vigilancia de Diabetes Mellitus
    Víctor Cornetero-Muro, Nélida Hilario Huapaya, Jorge Inolopú-Cucche, César Ugarte‐Gil, Yamilée Hurtado-Roca · 2021 · Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
100. A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia
     Chaicharn Deerochanawong, Kuan‐Cheng Chang, Yu Cho Woo, Wen‐Ter Lai, Aurauma Chutinet · 2022 · International Journal of Hypertension